Infacalm (Simeticone)

Simeticone works by reducing the surface tension of gas bubbles within the gastrointestinal tract. This physical action causes small bubbles to coalesce into larger ones, which can move more easily through the intestines and be expelled either by belching or passing wind. Because it acts locally and is not absorbed into the bloodstream, its effect is confined to the gut.

The appropriate dose of Infacalm is determined by a healthcare professional based on the individual’s age, weight, and severity of symptoms. As an over‑the‑counter product, it is typically taken as directed on the package label, but patients should follow the specific instructions provided by their prescriber or pharmacist.

Simeticone is minimally absorbed from the gastrointestinal tract, and limited data suggest low risk during pregnancy and lactation. Nevertheless, pregnant or breastfeeding individuals should consult their healthcare provider before using Infacalm to confirm that it is appropriate for their specific situation.

To place an order, submit an enquiry on the Infacalm product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Infacalm’s active ingredient, simeticone, differs from other antiflatulents such as activated charcoal or digestive enzymes because it works by physically altering gas bubbles rather than absorbing gas or altering digestion. This mechanism provides rapid relief with minimal systemic exposure, making it a preferred option for patients seeking a locally acting, well‑tolerated product.

Infacalm should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability and potency throughout its shelf life.

Infacalm is taken orally, usually in tablet, capsule or liquid form as indicated on the packaging. The product should be swallowed with water or mixed according to the label instructions. It can be taken with or without food, but patients should follow any specific guidance provided by their healthcare professional.

Although rare, serious adverse reactions may include allergic responses such as rash, itching, swelling, hives, or anaphylaxis. If any signs of a severe hypersensitivity reaction occur, the user should discontinue the product immediately and seek medical attention.

Infacalm should be avoided by individuals with a known hypersensitivity to simeticone or any of the product’s excipients. Additionally, patients with unexplained persistent abdominal pain or gastrointestinal disorders should consult a physician before using the product to rule out underlying conditions.